One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Amid competing priorities, dementia must not be forgotten
COVER\medimedia_training_video_5.png
doi : 10.1016/S1474-4422(21)00258-1
Volume 20, Issue 9, September 2021, Page 685
Trials and tribulations on the path to remyelination
Peter ACalabresia
doi : 10.1016/S1474-4422(21)00253-2
Volume 20, Issue 9, September 2021, Pages 686-687
A new thrombolytic drug for acute ischaemic stroke
Peter MRothwellaAlastair MBuchanb
doi : 10.1016/S1474-4422(21)00256-8
Volume 20, Issue 9, September 2021, Pages 687-689
BTK inhibitors as potential therapies for multiple sclerosis
JorgeCorrealea
doi : 10.1016/S1474-4422(21)00250-7
Volume 20, Issue 9, September 2021, Pages 689-691
A blood test for Alzheimer's disease: a step forward
LucillaParnettiaMassimiliano DiFilippoaLorenzoGaetania
doi : 10.1016/S1474-4422(21)00254-4
Volume 20, Issue 9, September 2021, Pages 691-693
The mechanisms of smell loss after SARS-CoV-2 infection
Richard LDotya
doi : 10.1016/S1474-4422(21)00202-7
Volume 20, Issue 9, September 2021, Pages 693-695
Clinical decision making in MOG antibody-associated disease
Russell CDaleabSudarshiniRamanathanac
doi : 10.1016/S1474-4422(21)00247-7
Volume 20, Issue 9, September 2021, Pages 695-697
Asymptomatic carotid stenosis and stroke risk
AnneAbbotta
doi : 10.1016/S1474-4422(21)00199-X
Volume 20, Issue 9, September 2021, Pages 698-699
Asymptomatic carotid stenosis and stroke risk – Authors' reply
Dominic P JHowardaPeter MRothwella
doi : 10.1016/S1474-4422(21)00262-3
Volume 20, Issue 9, September 2021, Page 699
The Dementia UK Ecosystem: a call to action
GiovannaLalliaMartinRossorbJames BRowecBartDe Strooperad
doi : 10.1016/S1474-4422(21)00246-5
Volume 20, Issue 9, September 2021, Pages 699-700
A call for better training in restless legs syndrome
CharlotteDeerenbergaJulieGouldbRachelAndrewsc
doi : 10.1016/S1474-4422(21)00244-1
Volume 20, Issue 9, September 2021, Pages 700-701
Improving access to the outdoors for people with dementia
EvaReali
doi : 10.1016/S1474-4422(21)00239-8
Volume 20, Issue 9, September 2021, Pages 702-703
Nursing homes with a difference: the outdoors inside
AineO'Connor
doi : 10.1016/S1474-4422(21)00260-X
Volume 20, Issue 9, September 2021, Pages 703-704
Emmanuelle Waubant: a most nautical neurologist
AdrianBurton
doi : 10.1016/S1474-4422(21)00261-1
Volume 20, Issue 9, September 2021, Page 705
Purkinje cells and their trees
Huda YZoghbiArpan RMehta
doi : 10.1016/S1474-4422(21)00243-X
Volume 20, Issue 9, September 2021, Page 706
Social prescribing for dementia
JohnGallacheraAlistairBurnsb
doi : 10.1016/S1474-4422(21)00208-8
Volume 20, Issue 9, September 2021, Pages 707-708
Does technology make us stupid?
PeterRanscombe
doi : 10.1016/S1474-4422(19)30350-3
Volume 20, Issue 9, September 2021, Page 708
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
J William LBrownPhDaeg*Nick GCunniffeMBBChira*FerranPradosPhDefhBarisKanberPhDefiJoanne LJonesPhDaEdwardNeedhamPhDaZoyaGeorgievaMBBSaDavidRogMDjOwen RPearsonMDkJamesOverellMDlmDavidMacManusMSceRebecca SSamsonPhDeJonathanStuttersBEngeProfCharlesffrench-ConstantPhDnProfClaudia A MGandini Wheeler-KingshottPhDepqCarlaMoranPhDbPaul DFlynnPhDcAndrew WMichellPhDaProfRobin J MFranklinPhDadProfSiddharthanChandranPhDnoDaniel RAltmannDPhilrDeclan TChardPhDeiPeterConnickPhDnProfAlasdair JColesPhDa
doi : 10.1016/S1474-4422(21)00179-4
Volume 20, Issue 9, September 2021, Pages 709-720
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
ProfEugene IGusevMDaProfMikhail YuMartynovMDaProfAlexey ANikonovMDaProfNikolay AShamalovMDbMichail PSemenovPhDcEugene AGerasimetsMDcProfElena BYarovayaPhDdAndrey MSemenovPhDcfProfAlexander IArchakovMDeProfSergey SMarkinMDef
doi : 10.1016/S1474-4422(21)00210-6
Volume 20, Issue 9, September 2021, Pages 721-728
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
ProfDaniel SReichMDaProfDouglas LArnoldMDbPatrickVermerschMDcProfAmitBar-OrMDdRobert JFoxMDeAndreMattaMDfTimothyTurnerPhDfErikWallströmMDfXinyanZhangPhDfMiroslavMarešMDgProfFarit AKhabirovMDhProfAnthonyTraboulseeMDi
doi : 10.1016/S1474-4422(21)00237-4
Volume 20, Issue 9, September 2021, Pages 729-738
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
Elisabeth HThijssenMScae*RenaudLa JoiePhDa*AmeliaStromBSaCorrinaFonsecaBSaLeonardoIaccarinoPhDaAmyWolfBSaSalvatoreSpinaMDaProfIsabel EAllenPhDbYannCobigoPhDaHilaryHeuerPhDaLawrenVandeVredeMDaNicholas KProctorBSfArgentina LarioLagoPhDaSuzanneBakerPhDgRajeevSivasankaranPhDhAgnieszkaKielochhArvindKinhikarPhDhLiliYuhMarie-AnneValentinPhDhAndreasJerominPhDiProfHenrikZetterbergMDjklmProfOskarHanssonMDnNiklasMattsson-CarlgrenMDnopDanielleGrahamPhDqProfKajBlennowMDjkProfJoel HKramerPsyDaLea TGrinbergMDacProfWilliam WSeeleyMDacProfHowardRosenMDaProfBradley FBoeveMDrProfBruce LMillerMDaProfCharlotte ETeunissenPhDeProfGil DRabinoviciMDadJulio CRojasMDaJeffrey LDagePhDfProfAdam LBoxerMDaon behalf of theAdvancing Research and Treatment for Frontotemporal Lobar Degeneration investigators†
doi : 10.1016/S1474-4422(21)00214-3
Volume 20, Issue 9, September 2021, Pages 739-752
Post-viral effects of COVID-19 in the olfactory system and their implications
Michael SXydakisMDaMark WAlbersMDcEric HHolbrookMDdDina MLyonMSaRobert YShihMDbProfJohannes AFrasnelliMDeProfAxelPagenstecherMDfAlexandraKupkeDVMgProfLynn WEnquistPhDh†ProfStanleyPerlmanMDi†
doi : 10.1016/S1474-4422(21)00182-4
Volume 20, Issue 9, September 2021, Pages 753-761
Myelin-oligodendrocyte glycoprotein antibody-associated disease
ProfRomainMarignierMDabcYaelHacohenMDdAlvaroCobo-CalvoMDeAnne-KatrinPröbstelMDfProfOrhanAktasMDgHarryAlexopoulosDphilhProfMaria-PiaAmatoMDiProfNasrinAsgariMDjProfBrendaBanwellMDklProfJeffreyBennettMDmFabienneBrilotMDnMarcoCapobiancoMDoProfTanujaChitnisMDpProfOlgaCiccarelliMDdProfKumaranDeivaMDqProfJérômeDe SèzeMDrProfKazuoFujiharaMDstAnuJacobMDuvProfHo JinKimMDvvProfIngoKleiterMDwxProfHansLassmannPhDyMaria-IsabelLeiteMDzProfChristopherLiningtonPhDaaProfEdgarMeinlMDabProfJacquelinePalaceMDzProfFriedemannPaulMDadProfAxelPetzoldMDaeafagProfSeanPittockMDahProfMarkusReindlPhDaiProfDouglas KazutoshiSatoMDajProfKrzysztofSelmajMDakalProfAkselSivaMDamProfBrunoStankoffMDanProfMarTintoreMDeProfAnthonyTraboulseeMDaoPatrickWatersPhDzProfEmmanuelleWaubantMDapProfBrianWeinshenkerMDaqProfTobiasDerfussMDfProfSandraVukusicMDabcProfBernhardHemmeraras
doi : 10.1016/S1474-4422(21)00218-0
Volume 20, Issue 9, September 2021, Pages 762-772
